PARD3A Antibodies

Santa Cruz Biotechnology offers a broad range of PARD3A monoclonal antibodies for various research applications. PARD3A monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PARD3A, or Partitioning Defective 3 Homolog A, plays a crucial role in cell polarity and is involved in the regulation of cell division and tissue organization. PARD3A function is essential for maintaining the structural integrity of epithelial tissues and has implications in cancer biology, as dysregulation can contribute to tumor progression. Understanding PARD3A in cellular processes is vital for advancing research in developmental biology and cancer therapeutics. PARD3A monoclonal antibodies enable researchers to investigate cell signaling pathways with precision and reliability. Studying PARD3A expression patterns helps reveal its role in tissue development and disease progression. PARD3A research continues to uncover new insights into cellular organization and cancer mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cellular processes and disease mechanisms.